Lignan complex derived from flaxseed as hypercholesterolemic and anti-atherosclerotic agent
AssigneeUniversity of Saskatchewan Technologies Inc.
InventorKailash Prasad
Life of this patent
Estimating the term…
Abstract
A method is described for treating hypercholesterolemic atherosclerosis or for reducing total cholesterol while raising high-density lipoportoein cholesterol. It involves administering to a patient a substantially pure complex derived from flaxseed and containing secoisolariciresinol diglucoside (SDG), cinnamic acid glucosides and hydroxymethyl glutaric acid.
Claims5
A method for treating hypercholesterolemic atherosclerosis or for reducing total cholesterol while raising high-density lipoprotein cholesterol which comprises administering to a patient an effective amount of a complex in substantially pure form derived from flaxseed and containing secoisolariciresinol diglucoside (SDG), cinnamic acid glucosides and hydroxymethyl glutaric acid.
Dependencies are inferred from the claim text.